Partner David Rosen was quoted in a Newsweek article published on May 1, 2014, titled “Be Still, My Bioficial Heart.” The article explained the benefits and challenges of creating a “bioficial heart,” which researchers at the University of Louisville recently announced could be developed using living cells from a potential transplant patient combined with artificial materials to create a fully functional 3-D printed heart. Given that the U.S. Food and Drug Administration (FDA) is many years out from approving lab-built organs for patients, Rosen said, “The potential challenges include demonstrating that the organs will function as predicted, demonstrating the sustainability of these organs once transplanted and obtaining approval to test and market these from [the] FDA.”
People
Related News
01 January 2025
In the News
Lauren Loew Highlights Illinois Genetic Privacy Law as Topic to Watch in 2025
Foley & Lardner LLP partner Lauren Loew highlighted the ongoing legal wrangling over Illinois' Genetic Information Privacy Act (GIPA) in the Law360 article, "Illinois Cases To Watch In 2025."
01 January 2025
In the News
Dennis Cardoza Highlights Key Energy Policy Focuses in 2025
Foley & Lardner Public Affairs Director Dennis Cardoza discussed key energy policy focuses for the new year in the Law360 article, "Top 5 Energy Policy Areas To Watch In 2025."
01 January 2025
In the News
Jeffery Atkin Shares Insight on Energy Sector Trends for 2025
Foley & Lardner LLP partner Jeffery Atkin shared perspective on energy sector trends for the year ahead in the Law360 article, "5 Energy Transactional Trends To Watch In 2025."